Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS‐CoV‐2 sensing by RIG‐I and MDA5 links epithelial infection to macrophage inflammation
Lucy Thorne, Ann‐Kathrin Reuschl, Lorena Zuliani‐Alvarez, et al.
The EMBO Journal (2021) Vol. 40, Iss. 15
Open Access | Times Cited: 203

Showing 1-25 of 203 citing articles:

Innate immunity: the first line of defense against SARS-CoV-2
Michael Diamond, Thirumala‐Devi Kanneganti
Nature Immunology (2022) Vol. 23, Iss. 2, pp. 165-176
Open Access | Times Cited: 508
Evolution of enhanced innate immune evasion by SARS-CoV-2
Lucy Thorne, Mehdi Bouhaddou, Ann‐Kathrin Reuschl, et al.
Nature (2021) Vol. 602, Iss. 7897, pp. 487-495
Open Access | Times Cited: 339
The development of COVID-19 treatment
Yongliang Yuan, Baihai Jiao, Lili Qu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 167
Innate immunological pathways in COVID-19 pathogenesis
Søren R. Paludan, Trine H. Mogensen
Science Immunology (2022) Vol. 7, Iss. 67
Closed Access | Times Cited: 164
Endothelial cells are not productively infected by SARS‐CoV‐2
Lilian Schimmel, Keng Yih Chew, Claudia J. Stocks, et al.
Clinical & Translational Immunology (2021) Vol. 10, Iss. 10
Open Access | Times Cited: 125
The RNA sensor MDA5 detects SARS-CoV-2 infection
Natália G. Sampaio, Lise Chauveau, Jonny Hertzog, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 120
The human genetic epidemiology of COVID-19
Mari Niemi, Mark J. Daly, Andrea Ganna
Nature Reviews Genetics (2022) Vol. 23, Iss. 9, pp. 533-546
Open Access | Times Cited: 119
Evolution of enhanced innate immune evasion by the SARS-CoV-2 B.1.1.7 UK variant
Lucy Thorne, Mehdi Bouhaddou, Ann‐Kathrin Reuschl, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 106
SARS-CoV-2 biology and host interactions
Silvio Steiner, Annika Kratzel, G. Tuba Barut, et al.
Nature Reviews Microbiology (2024) Vol. 22, Iss. 4, pp. 206-225
Closed Access | Times Cited: 83
S-217622, a SARS-CoV-2 main protease inhibitor, decreases viral load and ameliorates COVID-19 severity in hamsters
Michihito Sasaki, Koshiro Tabata, Mai Kishimoto, et al.
Science Translational Medicine (2022) Vol. 15, Iss. 679
Open Access | Times Cited: 79
TLR2 and TLR7 mediate distinct immunopathological and antiviral plasmacytoid dendritic cell responses to SARS‐CoV‐2 infection
Renée M. van der Sluis, Lamin B. Cham, Albert Gris‐Oliver, et al.
The EMBO Journal (2022) Vol. 41, Iss. 10
Open Access | Times Cited: 78
Innate immunity, cytokine storm, and inflammatory cell death in COVID-19
Rajendra Karki, Thirumala‐Devi Kanneganti
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 78
Recent developments in the immunopathology of COVID‐19
Huanping Zhang, Yuanli Sun, Yanfen Wang, et al.
Allergy (2022) Vol. 78, Iss. 2, pp. 369-388
Open Access | Times Cited: 76
Type I interferons and SARS-CoV-2: from cells to organisms
Paul Bastard, Qian Zhang, Shen‐Ying Zhang, et al.
Current Opinion in Immunology (2022) Vol. 74, pp. 172-182
Open Access | Times Cited: 71
SARS-CoV-2 variants evolve convergent strategies to remodel the host response
Mehdi Bouhaddou, Ann‐Kathrin Reuschl, Benjamin J. Polacco, et al.
Cell (2023) Vol. 186, Iss. 21, pp. 4597-4614.e26
Open Access | Times Cited: 71
The roles of critical pro‐inflammatory cytokines in the drive of cytokine storm during SARS‐CoV‐2 infection
Muhammad Suhaib Qudus, Mingfu Tian, Summan Sirajuddin, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 4
Open Access | Times Cited: 50
Evolution of enhanced innate immune suppression by SARS-CoV-2 Omicron subvariants
Ann‐Kathrin Reuschl, Lucy Thorne, Matthew Whelan, et al.
Nature Microbiology (2024) Vol. 9, Iss. 2, pp. 451-463
Open Access | Times Cited: 48
Covid-19 a triggering factor of autoimmune and multi-inflammatory diseases
Emina Karahmet Sher, Adnan Ćosović, Amina Džidić-Krivić, et al.
Life Sciences (2023) Vol. 319, pp. 121531-121531
Open Access | Times Cited: 46
MDA5-autoimmunity and interstitial pneumonitis contemporaneous with the COVID-19 pandemic (MIP-C)
Paula David, Saptarshi Sinha, Khizer Iqbal, et al.
EBioMedicine (2024) Vol. 104, pp. 105136-105136
Open Access | Times Cited: 17
The Immunopathogenesis of a Cytokine Storm: The Key Mechanisms Underlying Severe COVID-19
Luka Hiti, Tijana Markovič, Mitja Lainščak, et al.
Cytokine & Growth Factor Reviews (2025)
Open Access | Times Cited: 7
Why Does the Severity of COVID-19 Differ With Age?
Petra Zimmermann, Nigel Curtis
The Pediatric Infectious Disease Journal (2021) Vol. 41, Iss. 2, pp. e36-e45
Open Access | Times Cited: 79
Sensitivity to Vaccines, Therapeutic Antibodies, and Viral Entry Inhibitors and Advances To Counter the SARS-CoV-2 Omicron Variant
Hao Zhou, Michelle Møhlenberg, Jigarji Chaturji Thakor, et al.
Clinical Microbiology Reviews (2022) Vol. 35, Iss. 3
Open Access | Times Cited: 68
The battle between host and SARS-CoV-2: Innate immunity and viral evasion strategies
Shilei Zhang, Lulan Wang, Genhong Cheng
Molecular Therapy (2022) Vol. 30, Iss. 5, pp. 1869-1884
Open Access | Times Cited: 60
Viral and Bacterial Co-Infections in the Lungs: Dangerous Liaisons
Justine Oliva, Olivier Terrier
Viruses (2021) Vol. 13, Iss. 9, pp. 1725-1725
Open Access | Times Cited: 57
Page 1 - Next Page

Scroll to top